CCL14 and acute kidney injury: Meeting voting also showed general agreement that CCL14 values indicating low risk (≤ 1.30 ng/mL) could help with de-escalation or maintenance of AKI management strategies (agreed or somewhat agreed by 87.5% of the participants).